Lansoprazol Flas Viatris

Lansoprazole, the active ingredient in Lansoprazol Flas Viatris, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, erosive esophagitis and Helicobacter pylori infection.

GNH USA supplies Lansoprazol Flas Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid‑secretion pathway and is indicated for several gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): lowers esophageal acid exposure and promotes symptom relief. - Peptic ulcer disease: facilitates ulcer healing by suppressing gastric acid production. - Erosive esophagitis: aids mucosal recovery and reduces inflammation. - Helicobacter pylori eradication: used as part of combination therapy to improve bacterial clearance.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: feeling of stomach upset, usually mild. - Abdominal pain: discomfort or cramps in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea, abdominal cramping. - Elevated liver enzymes: signs of hepatic stress, monitored by labs. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Interstitial nephritis: kidney inflammation presenting with reduced urine output. - Hypomagnesemia: low magnesium levels causing muscle weakness or arrhythmias.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in patients with severe renal impairment. - Monitor for infection: be aware of increased risk of C. difficile colitis. - Avoid in known hypersensitivity: discontinue if allergic reactions develop. - Use caution in pregnancy: classified as Category B, discuss benefits with a healthcare provider. - Review concomitant medications that affect gastric pH: may alter absorption of other drugs. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazole may interact with several medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, compromising antiviral therapy. - High‑dose methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent monitoring. - Digoxin: altered serum levels, may need dose adjustment. - Diazepam: increased plasma concentration, potentially enhancing sedation.